IL6-110

N/A

Report date: 2024/06/17 16:33:51
NME

Base Information

Drug NameIL6-110
Drug Alias NameIL6-110IL6110
ClassificationOther
Mechanisms of ActionCyclin-dependent kinase 12 inhibitorsCyclin-dependent kinase 13 inhibitors
TargetsCyclin-dependent kinase 12Cyclin-dependent kinase 13
Therapy Area/IndicationsStomach NeoplasmsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIldong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesiLeadBMS Co Ltd
Inactive CompaniesN/A
Active IndicationsStomach NeoplasmsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A